Stock market announcement archive

LIFE: Financial calendar

May 10, 2023
Financial calendar for Lifecare ASFINANCIAL YEAR 202323.08.2023 - Half-yearly Report11.05.2023 - Quarterly Report - Q108.11.2023 - Quarterly Report - Q3This information is published pursuant to the requirements set out in theContinuing obligations.
Read more

LIFE: Financial calendar

May 5, 2023
Financial calendar for Lifecare ASFINANCIAL YEAR 202323.08.2023 - Half-yearly Report11.05.2023 - Quarterly Report - Q108.11.2023 - Quarterly Report - Q301.06.2023 - Capital Markets DayThis information is published pursuant to the requirements set out in theContinuing obligations.
Read more

LIFE: Financial calendar

May 5, 2023
Financial calendar for Lifecare ASFINANCIAL YEAR 202323.08.2023 - Half-yearly Report11.05.2023 - Quarterly Report - Q108.11.2023 - Quarterly Report - Q3This information is published pursuant to the requirements set out in theContinuing obligations.
Read more

LIFE: Lifecare signes lease agreement for 1000 sqm production and laboratory premises in Mainz

April 27, 2023
In solemn circumstances yesterday late afternoon, Lifecare signed a lease fornew production facilities and a laboratory in Mainz, Germany. The letter ofintent entered into last autumn has thus been formalized with InnovationsparkMainz GmbH & Co KG.- The lease of production premises ensures modern and effective facilitiesneeded for Lifecares planned scale up of production, with necessary […]
Read more

Minutes from Annual General Meeting – Re-election of Chairman

April 18, 2023
Bergen, Norway 18 April 2023 The Annual General Meeting of Lifecare AS was convened as a hybrid meeting on 18 April 2023. Morten Foros Krohnstad (Chairman of the Board) and Hans Johan Hekland (Board member) was re-elected as proposed by the Nomination Committee, with no alternative candidates proposed. All proposals on the agenda were adopted, […]
Read more

LIFE: Update on Sensor longevity

April 11, 2023
Reference is made to Lifecare AS (LIFE) stock exchange notification 6 February2023.Today, Lifecare is pleased to announce that a sensor first used in our ongoingClinical Development Study has confirmed an operational longevity of 12 weeks ina continued laboratory (in vitro) set up. This is yet another importantmilestone in the development of our Sencell technology for […]
Read more

Lifecare AS: Notification of Annual General Meeting

March 31, 2023
Bergen, Norway 31 March 2023The Annual General Meeting ("AGM") of Lifecare AS will be held on 18 April 2023at 10:00 CET. Notice of the AGM is enclosed to this announcement. Documents forthe AGM are available at www.lifecare.attme.dev/events/. The meeting will be conducted as a combined in-person and digital meeting.Shareholders who wish to participate and vote […]
Read more

LIFE: Update on Clinical Development Study

March 31, 2023
The Clinical Development Study with the Sencell sensor will continue for a fewmore weeks. - We operate complex and pioneering sensor technology and strive to ensure highquality at all stages of the process. We therefore want to extend the ClinicalDevelopment Study by a few weeks more than previously communicated, says CEOJoacim Holter. The sensors we […]
Read more

Lifecare’s Annual Report 2022: Important milestone achievements

March 28, 2023
For Lifecare 2022 was characterized by confirmation of the technology, ClinicalDevelopment Study, and building an organization that makes us even more robustand competent to face upcoming challenges. - Important milestone achievementsnaturally provide a good basis for the ongoing work related to the glucosesensor, CEO Joacim Holter states.- Our organization proved its capacity in full strength […]
Read more

LIFE: Successful ISO audit at Lifecare Laboratory in Germany

March 23, 2023
Lifecare is pleased to announce that its wholly owned subsidiary LifecareLaboratory GmbH in Mainz, Germany, has been successfully audited as part of theupcoming ISO certification. "It is reassuring that our operational organizationhas passed this audit without any major findings. This is a good fundament forour continued work on regulatory processes." says CEO Joacim Holter.Lifecare's main […]
Read more